Global Chlamydia Infections Pipeline Report 2016 - Review of 10 Companies & Drug Profiles - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Chlamydia Infections - Pipeline Review, H1 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for Chlamydia Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Chlamydia Infections and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Chlamydia Infections Overview
  3. Therapeutics Development
  4. Pipeline Products for Chlamydia Infections - Overview
  5. Pipeline Products for Chlamydia Infections - Comparative Analysis
  6. Chlamydia Infections - Therapeutics under Development by Companies
  7. Chlamydia Infections - Therapeutics under Investigation by Universities/Institutes
  8. Chlamydia Infections Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Chlamydia Infections - Products under Development by Companies
  13. Chlamydia Infections - Products under Investigation by Universities/Institutes
  14. Chlamydia Infections - Companies Involved in Therapeutics Development
  • Abera Bioscience AB
  • Adamis Pharmaceuticals Corporation
  • CEL-SCI Corporation
  • Genocea Biosciences, Inc.
  • Merck & Co., Inc.
  • NanoBio Corporation
  • Prokarium Limited
  • QureTech Bio AB
  • Selecta Biosciences, Inc.
  • SIGA Technologies, Inc.

For more information visit http://www.researchandmarkets.com/research/n8sn8k/chlamydia

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Infectious Diseases Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Infectious Diseases Drugs